Vimarsana
Biggest News Aggregation in the World

Page 30 - Scientific Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scientific Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scientific Development Today - Breaking & Trending Today

Microbial CDMO collaboration with Sacco System for live biotherapeutic products - Vimarsana News

Microbial CDMO collaboration with Sacco System for live biotherapeutic products

Manufacturing LBPs at industrial scale involves equipment and processing methods that can vary from those at development and semi-industrial scale. Sacco System can support your project all the way to commercial manufacture.

NurExone Announces Q4 and Full-year 2022 Financial Results and Provides Company Update, Highlighting 143.9% Scientific Research Investment Growth - Vimarsana News

NurExone Announces Q4 and Full-year 2022 Financial Results and Provides Company Update, Highlighting 143.9% Scientific Research Investment Growth

TORONTO and TEL AVIV, Israel, March 30, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (the "Company" or "NurExone") (TSXV: NRX) (FSE: J90) (NRX.V), a biopharmaceutical company developing biologically-guided

Liquid handling: Modernize your pipetting workflow - Vimarsana News

Liquid handling: Modernize your pipetting workflow

A cleverly designed liquid handling device can help combat common challenges and accelerate scientific development

Epistemic governance key: Kuwait PM - ARAB TIMES - Vimarsana News

Epistemic governance key: Kuwait PM - ARAB TIMES

KUWAIT CITY, Feb 13, (Agencies): To address challenges, manage crises, and diversify economies, the world needs to support epistemic modes of governance, said His Highness the Prime Minister of Kuwait Sheikh Ahmad Nawaf Al-Ahmad Al-Sabah on Monday. In his speech to the World Government Summit held i

Core One Labs Inc.: Core One Labs' Akome Signs Contract with University of Barcelona: Initiating Animal Model Studies on Psychedelics Drug Development to Combat a Variety of Neurological Diseases - Vimarsana News

Core One Labs Inc.: Core One Labs' Akome Signs Contract with University of Barcelona: Initiating Animal Model Studies on Psychedelics Drug Development to Combat a Variety of Neurological Diseases

VANCOUVER, BC / ACCESSWIRE / January 24, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN: A3CSSU) (the "Company" or "Core One"), in follow-up to its press release dated September 16